Literature DB >> 29402456

Identification of prolargin expression in articular cartilage and its significance in rheumatoid arthritis pathology.

Vinod Soman Pillai1, Rameshwari R Kundargi1, Fabia Edathadathil1, Sreepriya Nair1, Jai Thilak2, Roshini Anney Mathew1, Tessy Xavier1, Padmanabha Shenoy3, Krishnakumar N Menon4.   

Abstract

Qualitative 2D gel-electrophoresis (2DE) protein profiling for osteoarthritis (OA) and rheumatoid arthritis (RA) is challenging because of selective protein loss due to discrepancies in protein precipitation methodologies. Thus, we aimed at developing qualitative protein representation from OA/RA articular cartilage without protein precipitation towards identification of clinically relevant proteins. Chondroitinase digested human articular cartilages from RA patients were subjected to protein extraction using guanidinium hydrochloride (GuHCl) or 8 M urea with 10 or 2% ASB-14-4 or 0.45 M urea with 2% ASB-14-4 with cetylpyridinium chloride (CPC). The GuHCl extract is further protein precipitated with acetone or ammonium acetate-methanol or centricon-fractionated using 100 kDa cut filters and protein precipitated using ethanol. Processed extracts were subjected to 2DE to identify protein profiles. Poor proteins representations were observed in 2D gels with protein precipitated samples compared to qualitative protein representations seen in 2D gels of 0.45 M urea and 2%ASB-14-4 extraction procedure reproducibly. The strategy circumventing protein precipitation generated qualitative 2D gels. RA vs OA gel comparison showed elevated prolargin levels in RA with biglycan levels remaining unaltered. Up regulation of prolargin in RA suggests the likelihood of an adaptive mechanism to control the increased osteoclastogenesis in RA and may have therapeutic value in controlling the disease.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2D gel; Clinical significance; Human articular cartilage; Prolargin up regulation; Protein extraction

Mesh:

Substances:

Year:  2018        PMID: 29402456     DOI: 10.1016/j.ijbiomac.2018.01.141

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  1 in total

Review 1.  Emerging proteoglycans and proteoglycan-targeted therapies in rheumatoid arthritis.

Authors:  Brianna Hurysz; Nunzio Bottini
Journal:  Am J Physiol Cell Physiol       Date:  2022-04-27       Impact factor: 5.282

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.